SCHEMBL8263100

SCHEMBL8263100

CCC(=O)c1ccc(OC)c(OCCCOC)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
SMPD1 P17405 4/20 0.58
KDM4E B2RXH2 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.56
NPC1 O15118 1/20 0.56
HPGD P15428 1/20 0.56
RAB9A P51151 1/20 0.56
TP53 P04637 1/20 0.56
PDE4B Q07343 4/20 0.54
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
PRSS1 P07477 2/20 0.52
ALDH1A1 P00352 1/20 0.51
POLB P06746 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL88815 0.85 KMT2A (0.62) MEN1KMT2ASMPD1TP53CYP1A2
SCHEMBL31053926 0.85 MAPK1 (0.63) MEN1KMT2ASMPD1TP53PDE4B
SCHEMBL88998 0.85 CA12 (0.67) SMPD1TP53PDE4BPRSS1
SCHEMBL2438091 0.85 PDE4D (0.53) SMPD1TP53PDE4BPRSS1
SCHEMBL15202688 0.84 MAPK1 (0.67) MEN1KMT2AKDM4ESMN1; SMN2NPC1
SCHEMBL29578705 0.84 MEN1 (0.73) MEN1KMT2AKDM4ESMN1; SMN2NPC1
SCHEMBL515746 0.84 MEN1 (0.73) MEN1KMT2AKDM4ESMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL3372494 0.84 CA12 (0.65) SMPD1TP53PDE4BPRSS1
SCHEMBL56262 0.84 MAPT (0.60) MEN1KMT2ASMPD1KDM4ETP53
SCHEMBL2937932 0.84 SMPD1 (0.56) MEN1KMT2ASMPD1TP53PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006066896-A2 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN NOVARTIS AG (CH) 2006-06-29 WO disclosed